Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical Investigation

• Publication date

  2015-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI79048PMID 26368306PMCID PMC4607137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects

  2014cited by this paper
• HDL and cardiovascular disease.

  2014cited by this paper
• High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.

  2014cited by this paper
• HDL cholesterol efflux capacity and incident cardiovascular events.

  2014cited by this paper
• Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

  2014cited by this paper
• Genome-wide age-related changes in DNA methylation and gene expression in human PBMCs

  2014cited by this paper
• Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake.

  2014cited by this paper
• A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.

  2014cited by this paper
• Genome-wide age-related changes in DNA methylation and gene expression in human PBMCs

  2014cited by this paper
• Reverse cholesterol transport fluxes

  2014cited by this paper
• A Novel Role for Kruppel-like Factor 14 (KLF14) in T-Regulatory Cell Differentiation

  2014cited by this paper
• New Role for Kruppel-like Factor 14 as a Transcriptional Activator Involved in the Generation of Signaling Lipids*

  2014cited by this paper
• Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux

  2013cited by this paper
• RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

  2013cited by this paper
• RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist

  2013cited by this paper
• Mouse KLF11 regulates hepatic lipid metabolism.

  2013cited by this paper
• Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry).

  2013cited by this paper
• Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis

  2013cited by this paper
• Association of the KLF14 rs4731702 SNP and Serum Lipid Levels in the Guangxi Mulao and Han Populations

  2013cited by this paper
• Loss of Perivascular Adipose Tissue on Peroxisome Proliferator–Activated Receptor-&ggr; Deletion in Smooth Muscle Cells Impairs Intravascular Thermoregulation and Enhances Atherosclerosis

  2012cited by this paper
• Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans.

  2012cited by this paper
• Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments

  2012cited by this paper
• Genome‐wide association study validation identifies novel loci for atherosclerotic cardiovascular disease

  2012cited by this paper
• Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

  2012influential reference
• RVX 208

  2011cited by this paper
• Identification of an imprinted master trans-regulator at the KLF14 locus related to multiple metabolic phenotypes

  2011cited by this paper
• Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.

  2011cited by this paper
• Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice

  2011cited by this paper
• Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

  2011cited by this paper
• Association of New Loci Identified in European Genome-Wide Association Studies with Susceptibility to Type 2 Diabetes in the Japanese

  2011cited by this paper
• Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.

  2011cited by this paper
• Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations

  2011cited by this paper
• Inhibition of Gluconeogenic Genes by Calcium-regulated Heat-stable Protein 1 via Repression of Peroxisome Proliferator-activated Receptor α*

  2011cited by this paper
• Effects of perhexiline on myocardial deformation in patients with ischaemic left ventricular dysfunction.

  2010cited by this paper
• Mammalian Krüppel-like factors in health and diseases.

  2010cited by this paper
• A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome.

  2010cited by this paper
• Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids

  2010cited by this paper
• Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.

  2009cited by this paper
• Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

  2009cited by this paper
• Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction: Genomewide Analysis Among 18 245 Initially Healthy Women From the Women’s Genome Health Study

  2009cited by this paper
• Multi‐centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope

  2009cited by this paper
• New common variants affecting susceptibility to basal cell carcinoma

  2009cited by this paper
• Parental origin of sequence variants associated with complex diseases

  2009cited by this paper
• Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

  2009cited by this paper
• Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis

  2009cited by this paper
• Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

  2008cited by this paper
• Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.

  2008cited by this paper
• ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging.

  2008cited by this paper
• Perhexiline.

  2007cited by this paper
• Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

  2007cited by this paper
• Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention trial).

  2006cited by this paper
• Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model.

  2005cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

  2003cited by this paper
• Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target

  2002cited by this paper
• Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus*

  1999influential reference
• Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

  1999cited by this paper
• Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models.

  1999cited by this paper
• High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

  1989cited by this paper
• Unstable angina and perhexilene maleate.

  1981cited by this paper
• Perhexiline

  1980cited by this paper
• Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease.

  1978cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper

• Decoding the Kruppel-like Transcription Factors in Atherosclerosis: Insight from Molecular and Translational Perspectives

  2025cites this paper
• Genetic variations and functions of KLF14 in gene expression and metabolic disease development.

  2025cites this paper
• Adipocyte‐specific Krüppel‐like factor 14 overexpression confers sex‐biased protection from weight gain on a high‐fat diet

  2025cites this paper
• KLF14 and SREBF-1 Binding Site Associations with Orphan Receptor Promoters in Metabolic Syndrome

  2025cites this paper
• Epigenetic modifications in obesity‐associated diseases

  2024cites this paper
• The role of transcription factors in the pathogenesis and therapeutic targeting of vascular diseases

  2024cites this paper
• Krüppel-like transcription factor 14 alleviates alveolar epithelial cell senescence by inhibiting endoplasmic reticulum stress in pulmonaryfibrosis.

  2024cites this paper
• Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies

  2024cites this paper
• Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes

  2024cites this paper
• Biochemical Activation and Regulatory Functions of Trans-Regulatory KLF14 and Its Association with Genetic Polymorphisms

  2023influential citation
• Kruppel like factor 14 ameliorated obesity and related metabolic disorders by promoting adipose tissue browning.

  2023cites this paper
• Downregulation of Krüppel‐like factor 14 accelerated cellular senescence and aging

  2023influential citation
• Pan-primate studies of age and sex

  2023cites this paper
• Hepatic Krüppel‐like factor 14 regulates lipid metabolism in nonalcoholic steatohepatitis mice

  2023cites this paper
• Expression and function of long non-coding RNA DLX6-AS1 in endometrial cancer

  2023cites this paper
• Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology

  2023cites this paper
• KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2

  2023cites this paper
• The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis

  2022cites this paper
• Genetic Determinants of Cardiovascular Disease: The Endothelial Nitric Oxide Synthase 3 (eNOS3), Krüppel-Like Factor-14 (KLF-14), Methylenetetrahydrofolate Reductase (MTHFR), MiRNAs27a and Their Association with the Predisposition and Susceptibility to Coronary Artery Disease

  2022cites this paper
• Upregulation of KLF14 expression attenuates kidney fibrosis by inducing PPARα-mediated fatty acid oxidation.

  2022cites this paper
• Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models

  2022cites this paper
• HDL and ASCVD.

  2022cites this paper
• Differential Genetic and Epigenetic Effects of the KLF14 Gene on Body Shape Indices and Metabolic Traits

  2022cites this paper
• The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis

  2022cites this paper
• Krüppel-Like Factor 14 Deletion In Myeloid Cells Accelerates Atherosclerotic Lesion Development.

  2021influential citation
• Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation

  2021influential citation
• Adipocyte-specific modulation of KLF14 expression in mice leads to sex-dependent impacts in adiposity and lipid metabolism

  2021cites this paper
• Proteome-scale profiling reveals MAFF and MAFG as two novel key transcription factors involved in palmitic acid-induced umbilical vein endothelial cell apoptosis

  2021cites this paper
• KLF14 Inhibits Renal Mesangial Cell Proliferation by Promoting Btg2 Gene Expression

  2021cites this paper
• EZH2‐mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ

  2021cites this paper
• Advancing science and education through a novel collaboration platform between the University of Michigan and Peking University Health Science Center

  2021cites this paper
• Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases

  2021cites this paper
• The KLF14 Variant is Associated with Type 2 Diabetes and HbA1C Level

  2021cites this paper
• Krüppel-Like Factor 14 Improves Cardiac Function After Myocardial Infarction

  2020cites this paper
• The role of KLF14 in multiple disease processes

  2020cites this paper
• Role of de novo cholesterol synthesis enzymes in cancer

  2020cites this paper
• Treatment of coronary microvascular dysfunction.

  2020cites this paper
• mTORC1-dependent protein synthesis and autophagy uncouple in the regulation of Apolipoprotein A-I expression.

  2020cites this paper
• Endothelium‐targeted overexpression of Krüppel‐like factor 11 protects the blood‐brain barrier function after ischemic brain injury

  2020cites this paper
• Transcriptional and Epigenetic Regulation of Krüppel-Like Transcription Factors

  2020influential citation
• Transcription Factor KLF14 and Metabolic Syndrome

  2020influential citation
• Improvement of Endothelial Dysfunction of Berberine in Atherosclerotic Mice and Mechanism Exploring through TMT-Based Proteomics

  2020cites this paper
• Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport.

  2020cites this paper
• Pan-primate DNA methylation clocks

  2020cites this paper
• Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice

  2020cites this paper
• Genetics-driven discovery of novel regulators of lipid metabolism

  2019cites this paper
• New Trends in Vascular Inflammation Research: From Biology to Therapy

  2019influential citation
• Epigenetic Regulation of Fat Deposition: A Focus on Krüppel-Like Factor 14 (Klf14)

  2019cites this paper
• KLF14 potentiates oxidative adaptation via modulating HO-1 signaling in castrate-resistant prostate cancer.

  2019cites this paper
• Klf14 is an imprinted transcription factor that regulates placental growth.

  2019cites this paper
• Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo.

  2019cites this paper
• Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease.

  2019cites this paper
• Krüppel-like factor 14, a coronary artery disease associated transcription factor, inhibits endothelial inflammation via NF-κB signaling pathway.

  2018cites this paper
• Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.

  2018cites this paper
• Predicting trait regulators by identifying co-localization of DNA binding and GWAS variants in regulatory regions

  2018cites this paper
• Pathways for kidney triglyceride accumulation

  2018cites this paper
• The Krüppel-Like Factors and Control of Energy Homeostasis.

  2018cites this paper
• Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition

  2018cites this paper
• Overexpression of KLF14 protects against immune-mediated hepatic injury in mice

  2018cites this paper
• Brown Adipocyte-Specific PPAR&ggr; (Peroxisome Proliferator-Activated Receptor &ggr;) Deletion Impairs Perivascular Adipose Tissue Development and Enhances Atherosclerosis in Mice

  2018cites this paper
• Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease

  2018cites this paper
• Krüppel-Like Factors

  2018cites this paper
• Stimulation of KLF14/PLK1 pathway by thrombin signaling potentiates endothelial dysfunction in Type 2 diabetes mellitus.

  2018cites this paper
• Novel association between CDKAL1 and cholesterol efflux capacity: Replication after GWAS-based discovery.

  2018cites this paper
• CETP Deficiency and Concerns in CETP Inhibitor Development

  2017cites this paper
• The Association of HDL-C vs Apolipoprotein A-I with Risk of Coronary Heart Disease

  2017cites this paper
• Novel Approaches for HDL-Directed Therapies

  2017cites this paper
• Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease

  2017cites this paper
• Association of High‐Density Lipoprotein‐Cholesterol Versus Apolipoprotein A‐I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer‐Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study

  2017cites this paper
• Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression

  2017cites this paper
• HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics

  2017cites this paper
• A novel role for the Krüppel-like factor 14 on macrophage inflammatory response and atherosclerosis development.

  2017cites this paper
• SP and KLF Transcription Factors in Digestive Physiology and Diseases.

  2017cites this paper
• Germline deletion of Krüppel-like factor 14 does not increase risk of diet induced metabolic syndrome in male C57BL/6 mice.

  2017influential citation
• Cardiac metabolism — A promising therapeutic target for heart failure

  2017cites this paper
• The KLF14 transcription factor regulates hepatic gluconeogenesis in mice

  2017influential citation
• Identification and targeting of genes in atherosclerosis

  2017cites this paper
• Krüppel-like factors and vascular wall homeostasis

  2017cites this paper
• Drugs that Affect Cardiac Metabolism: Focus on Perhexiline

  2016cites this paper
• Experimental Biology for the Identification of Causal Pathways in Atherosclerosis

  2016cites this paper
• The Role of Genomic Imprints in Placental Biology

  2016cites this paper
• The Association between the KLF14 rs4731702 SNP and the Lipid Profile in Type 2 Diabetes Mellitus Patients: A Study in San Luis City, San Luis, Argentina

  2016cites this paper
• Low HDL and High HDL Syndromes

  2014cites this paper